Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol, stroke risk, and stroke prevention.

B J Ansell1

  • 1UCLA School of Medicine, Department of Internal Medicine, Division of General Internal Medicine/Health Services Research, 200 UCLA Medical Plaza, Suite 370-8, Los Angeles, CA 90095, USA.

Current Atherosclerosis Reports
|December 21, 2000
PubMed
Summary

Serum cholesterol predicts ischemic stroke risk but not hemorrhagic stroke risk. Statins effectively reduce stroke and cardiovascular events, especially in patients with atherosclerosis, by lowering low-density lipoprotein cholesterol.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing borderline levels of risk for coronary heart disease: two illustrative case presentations.

The Journal of the American Osteopathic Association·2001
Same author

Developing a clinical strategy for cholesterol management in an era of unanswered questions.

The American journal of cardiology·2001
Same author

Appropriate first-line lipid-lowering therapy for type 1 diabetes mellitus.

Archives of internal medicine·2001
Same author

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.

JAMA·1999
Same author

Visual tracking behavior in low functioning head-injured adults.

Archives of physical medicine and rehabilitation·1995
Same author

Slow-to-recover brain-injured patients: rationale for treatment.

Journal of speech and hearing research·1991

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Serum cholesterol is a complex predictor of stroke, positively linked to ischemic stroke and negatively to hemorrhagic stroke.
  • Older cholesterol-lowering drugs showed limited efficacy in stroke reduction.
  • Statins represent a newer class of lipid-lowering medications demonstrating significant cardiovascular and stroke benefits.

Purpose of the Study:

  • To evaluate the role of statins in stroke prevention.
  • To understand the shared mechanisms between ischemic stroke and coronary heart disease.
  • To identify patient groups who would most benefit from lipid reduction for stroke prevention.

Main Methods:

  • Review of existing studies on cholesterol, statins, and stroke outcomes.

Related Experiment Videos

  • Analysis of the association between lipid levels and different stroke types.
  • Examination of the therapeutic benefits of statins in cardiovascular disease and stroke.

    • Main Results:

    • Statins demonstrate consistent benefits in reducing both stroke and other cardiovascular events.
    • Ischemic stroke and coronary heart disease share underlying pathophysiological mechanisms, explaining statin efficacy.
    • Current research focuses on personalized lipid reduction strategies for stroke prevention.

    Conclusions:

    • Patients with established atherosclerosis should be treated with statins.
    • Target low-density lipoprotein cholesterol levels below 100 mg/dL for patients with atherosclerosis.
    • Statins are a key therapeutic option for managing cardiovascular risk and preventing stroke.